Net Cash Provided by (Used in) Operating Activities |
-789K |
USD |
+37.9% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
6.28K |
USD |
|
Q1 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
100M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
2.25M |
shares |
+35% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-789K |
USD |
+37.6% |
Q1 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
7.19K |
USD |
+86.1% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
11.7M |
USD |
+7.76% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
11.7M |
USD |
+7.76% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
8.6M |
USD |
+5.73% |
Q4 2023 |
FY 2023 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q2 2024 |
Q2 2024 |
Additional Paid in Capital |
49.2M |
USD |
+7.86% |
Q2 2024 |
Q2 2024 |
Share-based Payment Arrangement, Expense |
450K |
USD |
-66.4% |
Q2 2024 |
Q2 2024 |
Interest Expense |
21.8K |
USD |
+88.2% |
Q2 2024 |
Q2 2024 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |